Delivery Order SPE2DB22D3401-SPE2DB24FT1SQ

Award Date 2/3/24
Potential Completion Date 2/5/24
Potential Value $5.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,388.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a period of performance through September 7, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,609.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a pharmaceutical product, with a completion date of July 26, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $4,579.67, is for the delivery of 4555290801 TWINRIX VACCINE SYRINGEML. The award is a Firm Fixed Price Delivery Order with a completion date of November 3, 2021. The contract was made without a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
This federal contract award, valued at $144,528.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4557823055 Twinrix Vaccine syringes and has a completion date of June 17, 2022. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award, valued at $6,628.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a vaccine product, with a completion date of March 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $1,347.75 for the delivery of TWINRIX VACCINE SYRINGEML. The contract has a period of performance through June 6, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $3,314.40, is for the delivery of the TWINRIX VACCINE SYRINGE ML product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2024. The award was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $13,109.76, is for the delivery of TWINRIX VACCINE SYRINGEML, a vaccine product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 1, 2024. The award was made on February 29, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FNF47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,254.21, is for the delivery of the TWINRIX VACCINE SYRINGE.ML. It is a firm fixed-price delivery order contract with an ultimate completion date of October 24, 2023. The contract was awarded on October 23, 2023, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of TWINRIX VACCINE SYRINGES to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $3,447.90, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of May 9, 2024. Amerisourcebergen Drug Corp is a subsidiary of...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT1SQ
    Delivery Order

This federal contract award, valued at $5,249.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a vaccine product. It is a firm fixed-price delivery order contract with a completion date of February 5, 2024. The contract was awarded on February 3, 2024 and has no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/14/25, 9:59 AM